Find a clinical trial
A clinical trial is a research study that people can join. Some test a new treatment. Some test a new way to use a treatment we already have. Joining one is always your choice.
How to think about a clinical trial covers what taking part involves, when to ask, and what the phases mean.
Talk to your care team before you contact a trial. They know your history and can tell you whether a trial is worth your time. Nothing on this page is medical advice, and we are not part of any trial.
Trials near you
Enter your ZIP code to see open trials with a site within 50 miles. We use your ZIP only to run that search. We do not store it.
This box works for US ZIP codes only. Outside the US, use the country filter below to see trials in your country. It will not tell you how far away they are.
Trials by countries
Showing 478 trials. Trials we know are closed are left out. This list is the brain tumor trials we track, not every trial on ClinicalTrials.gov. The search above looks at all of them.
-
Testing furmonertinib with chemotherapy for EGFR lung cancer that has spread to the brain
This study compares two drug plans for lung cancer that has spread to the brain.
-
A scan study of PSMA in glioblastoma during bevacizumab treatment
This study uses a special scan to look at brain tumors in people taking bevacizumab.
-
A study of the drug RYZ101 for meningioma that grows or comes back
This study is testing whether a radioactive drug called RYZ101 can help with meningioma.
-
A study of how the brain changes during glioma treatment
This study watches how the brain adapts while a person is treated for glioma.
-
A study of Cerebellar Mutism Syndrome in children after brain tumor surgery
This study looks at why some children get a condition called Cerebellar Mutism Syndrome after surgery for a brain tumor.
-
DFMO tested as follow-up treatment for medulloblastoma
This trial is testing a drug called DFMO in people with a brain tumor called medulloblastoma.
-
A study drug called PLX038 for brain and spinal cord tumors
This trial is testing a drug called PLX038 in adults who have a tumor of the brain or spinal cord.
-
A remote exercise program for young brain tumor survivors who feel very tired
This study is testing whether a guided exercise program can help young brain tumor survivors who deal with deep tiredness from cancer.
-
Testing CAR T cells put into the brain for high-grade glioma that came back or is getting worse
This trial is testing a treatment made from a person's own immune cells, placed right into the brain.
-
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
From the trial team: This phase I trial studies the safety and side effects of a new positron emission tomography (PET) imaging agent called 64Cu-DOTA-pembrolizumab to see how well it works in determining treatment response for patients with stage IV non-small cell lung cancer (NSCLC) already receiving pembrolizumab.
-
A study of balance after Gamma Knife treatment for a vestibular schwannoma
This study follows how balance changes in people treated with Gamma Knife radiation for a benign tumor near the hearing and balance nerve.
-
Testing a treatment plan built for each person's tumor in children and young adults whose medulloblastoma or ependymoma has come back
This study tests whether a care team can build a treatment plan that fits one person's own tumor.
-
Testing a GD2 CAR T cell therapy in children and young adults with diffuse midline glioma
This study is testing a CAR T cell therapy aimed at GD2 in young people with a brain tumor called diffuse midline glioma.
-
Mirdametinib with vinblastine chemotherapy for newly diagnosed PLGG
This study is testing a drug taken by mouth, mirdametinib, given together with vinblastine chemotherapy in people with newly diagnosed PLGG.
-
Testing a targeted radiation drug with lomustine for glioblastoma that has come back
This trial is testing whether adding a targeted radiation drug to lomustine helps adults whose glioblastoma has come back.
-
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
From the trial team: A open-label drug-drug interaction (DDI) study to evaluate the effects of olutasidenib on the pharmacokinetics (PK) of a CYP450 and OATP1B1 probe substrate cocktail in participants with IDH1 mutation-positive malignancies.
-
Testing levetiracetam added to standard treatment for hypoxic IDH-wildtype glioblastoma
This study asks if adding a drug called levetiracetam to the usual glioblastoma treatment helps people do better.
-
Placing a small fluid port during brain tumor surgery to collect samples for research
This study is testing whether a small device called an Ommaya reservoir can be placed safely during brain tumor surgery so doctors can collect fluid from around the brain over time.
-
Testing two drugs after focused radiation for lymphoma in the brain and spinal cord
This study is testing whether two drugs given after focused radiation are safe and helpful for people with lymphoma in the brain or spinal cord.
-
Testing a phone app to deliver glioma treatment at home
This study is testing a mobile app that lets people with glioma get therapy at home and stay in touch with their care team.
Trial information comes from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. We copy it as it is published there and do not change it. Always check the trial's own page for the latest.